-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Choosing Wisely® Campaign: 2022 ASH Choosing Wisely Champions

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Adverse Events, Technology and Procedures
Monday, December 12, 2022: 12:15 PM-1:15 PM
243-245 (Ernest N. Morial Convention Center)
Marc Stuart Zumberg, MD, University of Florida
Zumberg: law case review: Consultancy; American Board of Internal Medicine: Honoraria; Veralox Therapeutics: Consultancy.
In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.

Carol M. Mathew, MD

University of Florida, Gainesville, FL

Daanish Hoda, MD

Intermountain Health, LDS Hospital, Salt Lake City, UT

Kamal K Sahu, MD, DM

Huntsman Cancer Institute, University of Utah, Salk Lake City, UT